FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Lisbeth Illum

Research Profile

Procedures

Objects

Microspheres

Chemicals & Drugs

Concepts & Ideas

Living Beings

Anatomy

Nasal Mucosa

Devices

Drug Delivery Systems

Phenomena

Occupations

Chemistry, Pharmaceutical

Co-author Network

Publications

TOP 3
Meera Vijayaraghavan; Snjezana Stolnik; Steven M Howdle; Lisbeth Illum
Suitability of polymer materials for production of pulmonary microparticles using a PGSS supercritical fluid technique: preparation of microparticles using PEG, fatty acids and physical or chemicals blends of PEG and fatty acids.
Meera Vijayaraghavan; Snjezana Stolnik; Steven M Howdle; Lisbeth Illum
Suitability of polymer materials for production of pulmonary microparticles using a PGSS supercritical fluid technique: thermodynamic behaviour of fatty acids, PEGs and PEG-fatty acids.
Luca Casettari; Jenny K W Lam; Mahmoud Soliman; Driton Vllasaliu; Lisbeth Illum
Biomedical applications of amino acid-modified chitosans: a review.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Lisbeth Illum (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Meera Vijayaraghavan; Snjezana Stolnik; Steven M Howdle; Lisbeth Illum
Suitability of polymer materials for production of pulmonary microparticles using a PGSS supercritical fluid technique: preparation of microparticles using PEG, fatty acids and physical or chemicals blends of PEG and fatty acids.
International journal of pharmaceutics 2013;441(1-2):580-8.
2012: Meera Vijayaraghavan; Snjezana Stolnik; Steven M Howdle; Lisbeth Illum
Suitability of polymer materials for production of pulmonary microparticles using a PGSS supercritical fluid technique: thermodynamic behaviour of fatty acids, PEGs and PEG-fatty acids.
International journal of pharmaceutics 2012;438(1-2):225-31.
2012: Luca Casettari; Jenny K W Lam; Mahmoud Soliman; Driton Vllasaliu; Lisbeth Illum
Biomedical applications of amino acid-modified chitosans: a review.
Biomaterials 2012;33(30):7565-83.
2012: Driton Vllasaliu; Luca Casettari; Ruth Exposito-Harris; Robyn Fowler; Martin Garnett; Lisbeth Illum; Snjezana Stolnik
Absorption-promoting effects of chitosan in airway and intestinal cell lines: a comparative study.
International journal of pharmaceutics 2012;430(1-2):151-60.
2012: Catherine A Kelly; Graham Coxhill; Steven M Howdle; Lisbeth Illum; Andrew Naylor; Laura C Tye; Andrew L Lewis
Stability of human growth hormone in supercritical carbon dioxide.
Journal of pharmaceutical sciences 2012;101(1):56-67.
2010: Driton Vllasaliu; Ruth Exposito-Harris; Angeles Heras; Luca Casettari; Martin Garnett; Lisbeth Illum; Snjezana Stolnik
Tight junction modulation by chitosan nanoparticles: comparison with chitosan solution.
International journal of pharmaceutics 2010;400(1-2):183-93.
2009: Alpesh Mistry; Snjezana Stolnik; Lisbeth Illum
Nanoparticles for direct nose-to-brain delivery of drugs.
International journal of pharmaceutics 2009;379(1):146-57.
2009: Alpesh Mistry; Sys Zoffmann Glud; Jørgen Kjems; Jens Randel; Kenneth Alan Howard; Snjezana Stolnik; Lisbeth Illum
Effect of physicochemical properties on intranasal nanoparticle transit into murine olfactory epithelium.
Journal of drug targeting 2009;17(7):543-52.
2008: Stuart T Charlton; Joanne Whetstone; Susan T Fayinka; Kevin D Read; Lisbeth Illum; Stanley S Davis
Evaluation of direct transport pathways of glycine receptor antagonists and an angiotensin antagonist from the nasal cavity to the central nervous system in the rat model.
Pharmaceutical research 2008;25(7):1531-43.
2007: Stuart T Charlton; Stanley S Davis; Lisbeth Illum
Nasal administration of an angiotensin antagonist in the rat model: effect of bioadhesive formulations on the distribution of drugs to the systemic and central nervous systems.
International journal of pharmaceutics 2007;338(1-2):94-103.
2007: Henry R Costantino; Lisbeth Illum; Gordon C Brandt; Paul H Johnson; Steven Quay
Intranasal delivery: physicochemical and therapeutic aspects.
International journal of pharmaceutics 2007;337(1-2):1-24.
2007: Stuart T Charlton; Stanley S Davis; Lisbeth Illum
Evaluation of effect of ephedrine on the transport of drugs from the nasal cavity to the systemic circulation and the central nervous system.
Journal of drug targeting 2007;15(5):370-7.
2007: Stuart T Charlton; Stanley S Davis; Lisbeth Illum
Evaluation of bioadhesive polymers as delivery systems for nose to brain delivery: in vitro characterisation studies.
Journal of controlled release : official journal of the Controlled Release Society 2007;118(2):225-34.
2007: Stuart T Charlton; Nick S Jones; Stanley S Davis; Lisbeth Illum
Distribution and clearance of bioadhesive formulations from the olfactory region in man: effect of polymer type and nasal delivery device.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2007;30(3-4):295-302.
2007: Lisbeth Illum
Nanoparticulate systems for nasal delivery of drugs: a real improvement over simple systems?
Journal of pharmaceutical sciences 2007;96(3):473-83.
2006: Lisbeth Illum
Nasal clearance in health and disease.
Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine 2006;19(1):92-9.
2005: Snjezana Stolnik; CR Heald; M G Garnett; Lisbeth Illum; Stanley S Davis
Differences in the adsorption behaviour of poly(ethylene oxide) copolymers onto model polystyrene nanoparticles assessed by isothermal titration microcalorimetry correspond to the biological differences.
Journal of drug targeting 2005;13(8-9):449-58.
2005: Robert C Read; Simone C Naylor; Christopher W Potter; Jenny Bond; Inderjit Jabbal-Gill; Anthony Fisher; Lisbeth Illum; Roy Jennings
Effective nasal influenza vaccine delivery using chitosan.
Vaccine 2005;23(35):4367-74.
2004: M M Leane; Richard Nankervis; Alan Smith; Lisbeth Illum
Use of the ninhydrin assay to measure the release of chitosan from oral solid dosage forms.
International journal of pharmaceutics 2004;271(1-2):241-9.
2004: Edel A McNeela; Inderjit Jabbal-Gill; Lisbeth Illum; Mariagrazia Pizza; Rino Rappuoli; Audino Podda; David J M Lewis; Kingston H G Mills
Intranasal immunization with genetically detoxified diphtheria toxin induces T cell responses in humans: enhancement of Th2 responses and toxin-neutralizing antibodies by formulation with chitosan.
Vaccine 2004;22(8):909-14.
2004: Lisbeth Illum
Is nose-to-brain transport of drugs in man a reality?
The Journal of pharmacy and pharmacology 2004;56(1):3-17.
2003: Lisbeth Illum; Michael Hinchcliffe; Stanley S Davis
The effect of blood sampling site and physicochemical characteristics of drugs on bioavailability after nasal administration in the sheep model.
Pharmaceutical research 2003;20(9):1474-84.
2003: Monica Fee; Neil Errington; Kornelia Jumel; Lisbeth Illum; Alan Smith; Stephen E Harding
Correlation of SEC/MALLS with ultracentrifuge and viscometric data for chitosans.
European biophysics journal : EBJ 2003;32(5):457-64.
2003: M Iqbal; Wu Lin; Inderjit Jabbal-Gill; Stanley S Davis; Michael W Steward; Lisbeth Illum
Nasal delivery of chitosan-DNA plasmid expressing epitopes of respiratory syncytial virus (RSV) induces protective CTL responses in BALB/c mice.
Vaccine 2003;21(13-14):1478-85.
2003: Lisbeth Illum
Nasal drug delivery--possibilities, problems and solutions.
Journal of controlled release : official journal of the Controlled Release Society 2003;87(1-3):187-98.
2003: Kingston H G Mills; Catherine Cosgrove; Edel A McNeela; Amy Sexton; Rafaela Giemza; Inderjit Jabbal-Gill; Anne Church; Wu Lin; Lisbeth Illum; Audino Podda; Rino Rappuoli; Mariagrazia Pizza; George E Griffin; David J M Lewis
Protective levels of diphtheria-neutralizing antibody induced in healthy volunteers by unilateral priming-boosting intranasal immunization associated with restricted ipsilateral mucosal secretory immunoglobulin a.
Infection and immunity 2003;71(2):726-32.
2003: Stanley S Davis; Lisbeth Illum
Absorption enhancers for nasal drug delivery.
Clinical pharmacokinetics 2003;42(13):1107-28.
2002: Lisbeth Illum
Nasal drug delivery: new developments and strategies.
Drug discovery today 2002;7(23):1184-9.
2002: A M Dyer; Michael Hinchcliffe; Peter Watts; J Castile; Inderjit Jabbal-Gill; Richard Nankervis; Alan Smith; Lisbeth Illum
Nasal delivery of insulin using novel chitosan based formulations: a comparative study in two animal models between simple chitosan formulations and chitosan nanoparticles.
Pharmaceutical research 2002;19(7):998-1008.
2002: Lisbeth Illum; Peter Watts; AN Fisher; Michael Hinchcliffe; H Norbury; Inderjit Jabbal-Gill; Richard Nankervis; Stanley S Davis
Intranasal delivery of morphine.
The Journal of pharmacology and experimental therapeutics 2002;301(1):391-400.
2002: Yu Hui Cheng; Peter Watts; Michael Hinchcliffe; R Hotchkiss; Richard Nankervis; N F Faraj; Alan Smith; Stanley S Davis; Lisbeth Illum
Development of a novel nasal nicotine formulation comprising an optimal pulsatile and sustained plasma nicotine profile for smoking cessation.
Journal of controlled release : official journal of the Controlled Release Society 2002;79(1-3):243-54.
2001: Snjezana Stolnik; B Daudali; A Arien; Joanne Whetstone; CR Heald; Martin C Garnett; Stanley S Davis; Lisbeth Illum
The effect of surface coverage and conformation of poly(ethylene oxide) (PEO) chains of poloxamer 407 on the biological fate of model colloidal drug carriers.
Biochimica et biophysica acta 2001;1514(2):261-79.
2001: Inderjit Jabbal-Gill; Wu Lin; O Kistner; Stanley S Davis; Lisbeth Illum
Polymeric lamellar substrate particles for intranasal vaccination.
Advanced drug delivery reviews 2001;51(1-3):97-111.
2001: Lisbeth Illum; Inderjit Jabbal-Gill; Michael Hinchcliffe; AN Fisher; Stanley S Davis
Chitosan as a novel nasal delivery system for vaccines.
Advanced drug delivery reviews 2001;51(1-3):81-96.
2001: Thirumala Govender; Snjezana Stolnik; C Xiong; S Zhang; Lisbeth Illum; Stanley S Davis
Drug-polyionic block copolymer interactions for micelle formation: physicochemical characterisation.
Journal of controlled release : official journal of the Controlled Release Society 2001;75(3):249-58.
2001: Lisbeth Illum; AN Fisher; Inderjit Jabbal-Gill; Stanley S Davis
Bioadhesive starch microspheres and absorption enhancing agents act synergistically to enhance the nasal absorption of polypeptides.
International journal of pharmaceutics 2001;222(1):109-19.
2001: Lisbeth Illum; A E Church; M D Butterworth; A Arien; Joanne Whetstone; Stanley S Davis
Development of systems for targeting the regional lymph nodes for diagnostic imaging: in vivo behaviour of colloidal PEG-coated magnetite nanospheres in the rat following interstitial administration.
Pharmaceutical research 2001;18(5):640-5.
2001: RJ Soane; Michael Hinchcliffe; Stanley S Davis; Lisbeth Illum
Clearance characteristics of chitosan based formulations in the sheep nasal cavity.
International journal of pharmaceutics 2001;217(1-2):183-91.
2001: W Lin; Martin C Garnett; Stanley S Davis; Etienne Schacht; Paolo Ferruti; Lisbeth Illum
Preparation and characterisation of rose Bengal-loaded surface-modified albumin nanoparticles.
Journal of controlled release : official journal of the Controlled Release Society 2001;71(1):117-26.
2001: H M Redhead; Stanley S Davis; Lisbeth Illum
Drug delivery in poly(lactide-co-glycolide) nanoparticles surface modified with poloxamer 407 and poloxamine 908: in vitro characterisation and in vivo evaluation.
Journal of controlled release : official journal of the Controlled Release Society 2001;70(3):353-63.
2001: RJ Soane; A S Carney; Nick S Jones; Malcolm Frier; Alan C Perkins; Stanley S Davis; Lisbeth Illum
The effect of the nasal cycle on mucociliary clearance.
Clinical otolaryngology and allied sciences 2001;26(1):9-15.
2001: Snjezana Stolnik; CR Heald; J Neal; Martin C Garnett; Stanley S Davis; Lisbeth Illum; S C Purkis; R J Barlow; P R Gellert
Polylactide-poly(ethylene glycol) micellar-like particles as potential drug carriers: production, colloidal properties and biological performance.
Journal of drug targeting 2001;9(5):361-78.
2001: J Brooking; Stanley S Davis; Lisbeth Illum
Transport of nanoparticles across the rat nasal mucosa.
Journal of drug targeting 2001;9(4):267-79.
2001: Stanley S Davis; Lisbeth Illum; Michael Hinchcliffe
Gastrointestinal transit of dosage forms in the pig.
The Journal of pharmacy and pharmacology 2001;53(1):33-9.
2000: Edel A McNeela; D O'Connor; Inderjit Jabbal-Gill; Lisbeth Illum; Stanley S Davis; Mariagrazia Pizza; Samuele Peppoloni; Rino Rappuoli; Kingston H G Mills
A mucosal vaccine against diphtheria: formulation of cross reacting material (CRM(197)) of diphtheria toxin with chitosan enhances local and systemic antibody and Th2 responses following nasal delivery.
Vaccine 2000;19(9-10):1188-98.
2000: A Bacon; Jill Makin; P J Sizer; Inderjit Jabbal-Gill; Michael Hinchcliffe; Lisbeth Illum; Steven N Chatfield; Mark Roberts
Carbohydrate biopolymers enhance antibody responses to mucosally delivered vaccine antigens.
Infection and immunity 2000;68(10):5764-70.
2000: Lisbeth Illum
Transport of drugs from the nasal cavity to the central nervous system.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2000;11(1):1-18.
2000: Thirumala Govender; T Riley; Touraj Ehtezazi; Martin C Garnett; Snjezana Stolnik; Lisbeth Illum; Stanley S Davis
Defining the drug incorporation properties of PLA-PEG nanoparticles.
International journal of pharmaceutics 2000;199(1):95-110.
2000: Y H Cheng; Lisbeth Illum; Stanley S Davis
Schizophrenia and drug delivery systems.
Journal of drug targeting 2000;8(2):107-17.
1999: W Lin; Martin C Garnett; Etienne Schacht; Stanley S Davis; Lisbeth Illum
Preparation and in vitro characterization of HSA-mPEG nanoparticles.
International journal of pharmaceutics 1999;189(2):161-70.
1999: P He; Stanley S Davis; Lisbeth Illum
Chitosan microspheres prepared by spray drying.
International journal of pharmaceutics 1999;187(1):53-65.
1999: Inderjit Jabbal-Gill; Wu Lin; P Jenkins; Peter Watts; M Jimenez; Lisbeth Illum; Stanley S Davis; J M Wood; D Major; Philip D Minor; X Li; E C Lavelle; A G A Coombes
Potential of polymeric lamellar substrate particles (PLSP) as adjuvants for vaccines.
Vaccine 1999;18(3-4):238-50.
1999: Thirumala Govender; Touraj Ehtezazi; Snjezana Stolnik; Lisbeth Illum; Stanley S Davis
Complex formation between the anionic polymer (PAA) and a cationic drug (procaine HCI): characterization by microcalorimetric studies.
Pharmaceutical research 1999;16(7):1125-31.
1999: P D Scholes; A G A Coombes; Lisbeth Illum; Stanley S Davis; JF Watts; C Ustariz; M Vert; Martyn C Davies
Detection and determination of surface levels of poloxamer and PVA surfactant on biodegradable nanospheres using SSIMS and XPS.
Journal of controlled release : official journal of the Controlled Release Society 1999;59(3):261-78.
1999: P He; Stanley S Davis; Lisbeth Illum
Sustained release chitosan microspheres prepared by novel spray drying methods.
Journal of microencapsulation 1999;16(3):343-55.
1999: RJ Soane; Malcolm Frier; Alan C Perkins; Nick S Jones; Stanley S Davis; Lisbeth Illum
Evaluation of the clearance characteristics of bioadhesive systems in humans.
International journal of pharmaceutics 1999;178(1):55-65.
1999: Thirumala Govender; Snjezana Stolnik; Martin C Garnett; Lisbeth Illum; Stanley S Davis
PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug.
Journal of controlled release : official journal of the Controlled Release Society 1999;57(2):171-85.
1998: Inderjit Jabbal-Gill; AN Fisher; Rino Rappuoli; Stanley S Davis; Lisbeth Illum
Stimulation of mucosal and systemic antibody responses against Bordetella pertussis filamentous haemagglutinin and recombinant pertussis toxin after nasal administration with chitosan in mice.
Vaccine 1998;16(20):2039-46.
1998: Y H Cheng; Lisbeth Illum; Stanley S Davis
A poly(D,L-lactide-co-glycolide) microsphere depot system for delivery of haloperidol.
Journal of controlled release : official journal of the Controlled Release Society 1998;55(2-3):203-12.
1998: J C Neal; Snjezana Stolnik; Etienne Schacht; E R Kenawy; Martin C Garnett; Stanley S Davis; Lisbeth Illum
In vitro displacement by rat serum of adsorbed radiolabeled poloxamer and poloxamine copolymers from model and biodegradable nanospheres.
Journal of pharmaceutical sciences 1998;87(10):1242-8.
1998: Lisbeth Illum
Chitosan and its use as a pharmaceutical excipient.
Pharmaceutical research 1998;15(9):1326-31.
1998: AE Hawley; Lisbeth Illum; Stanley S Davis
The effect of lymphatic oedema on the uptake of colloids to the lymph nodes.
Biopharmaceutics & drug disposition 1998;19(3):193-7.
1998: J C Neal; Snjezana Stolnik; Martin C Garnett; Stanley S Davis; Lisbeth Illum
Modification of the copolymers poloxamer 407 and poloxamine 908 can affect the physical and biological properties of surface modified nanospheres.
Pharmaceutical research 1998;15(2):318-24.
1998: I J Gill; AN Fisher; N Farraj; C G Pitt; Stanley S Davis; Lisbeth Illum
Intranasal absorption of granulocyte-colony stimulating factor (G-CSF) from powder formulations, in sheep.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 1998;6(1):1-10.
1997: TI Armstrong; SM Moghimi; Stanley S Davis; Lisbeth Illum
Activation of the mononuclear phagocyte system by poloxamine 908: its implications for targeted drug delivery.
Pharmaceutical research 1997;14(11):1629-33.
1997: A G A Coombes; S Tasker; M Lindblad; J Holmgren; K Hoste; Veska Toncheva; Etienne Schacht; Martyn C Davies; Lisbeth Illum; Stanley S Davis
Biodegradable polymeric microparticles for drug delivery and vaccine formulation: the surface attachment of hydrophilic species using the concept of poly(ethylene glycol) anchoring segments.
Biomaterials 1997;18(17):1153-61.
1997: J Vandorpe; E Schacht; S Dunn; AE Hawley; Snjezana Stolnik; Stanley S Davis; Martin C Garnett; M C Davies; Lisbeth Illum
Long circulating biodegradable poly(phosphazene) nanoparticles surface modified with poly(phosphazene)-poly(ethylene oxide) copolymer.
Biomaterials 1997;18(17):1147-52.
1997: AE Hawley; Lisbeth Illum; Stanley S Davis
Preparation of biodegradable, surface engineered PLGA nanospheres with enhanced lymphatic drainage and lymph node uptake.
Pharmaceutical research 1997;14(5):657-61.
1997: T J Aspden; J D Mason; Nick S Jones; J Lowe; O Skaugrud; Lisbeth Illum
Chitosan as a nasal delivery system: the effect of chitosan solutions on in vitro and in vivo mucociliary transport rates in human turbinates and volunteers.
Journal of pharmaceutical sciences 1997;86(4):509-13.
1997: W Lin; Martin C Garnett; Martyn C Davies; Fabio Bignotti; Paolo Ferruti; Stanley S Davis; Lisbeth Illum
Preparation of surface-modified albumin nanospheres.
Biomaterials 1997;18(7):559-65.
1997: AE Hawley; Lisbeth Illum; Stanley S Davis
Lymph node localisation of biodegradable nanospheres surface modified with poloxamer and poloxamine block co-polymers.
FEBS letters 1997;400(3):319-23.
1997: TI Armstrong; M C Davies; Lisbeth Illum
Human serum albumin as a probe for protein adsorption to nanoparticles: relevance to biodistribution.
Journal of drug targeting 1997;4(6):389-98.
1997: TI Armstrong; Lisbeth Illum
Human serum albumin as a probe for surface conditioning--a study of the ageing effect.
Journal of drug targeting 1997;4(5):331-5.
1996: Lisbeth Illum; Stanley S Davis; M Pawula; AN Fisher; David A Barrett; N F Farraj; P Nicholas Shaw
Nasal administration of morphine-6-glucuronide in sheep--a pharmacokinetic study.
Biopharmaceutics & drug disposition 1996;17(8):717-24.
1996: N Gardner; W Haresign; R Spiller; N Farraj; J Wiseman; H Norbury; Lisbeth Illum
Development and validation of a pig model for colon-specific drug delivery.
The Journal of pharmacy and pharmacology 1996;48(7):689-93.
1995: J D Mason; T J Aspden; J Adler; N S Jones; Lisbeth Illum; S S Davis
Measurement of nasal mucociliary transport rates on the isolated human inferior turbinate.
Clinical otolaryngology and allied sciences 1995;20(6):530-5.
1995: E S Cahill; D T O'Hagan; Lisbeth Illum; A Barnard; Kingston H G Mills; K Redhead
Immune responses and protection against Bordetella pertussis infection after intranasal immunization of mice with filamentous haemagglutinin in solution or incorporated in biodegradable microparticles.
Vaccine 1995;13(5):455-62.
1994: S G Chandler; N W Thomas; Lisbeth Illum
Nasal absorption in the rat. III. Effect of lysophospholipids on insulin absorption and nasal histology.
Pharmaceutical research 1994;11(11):1623-30.
1994: W Lin; A G A Coombes; Martin C Garnett; Martyn C Davies; Etienne Schacht; Stanley S Davis; Lisbeth Illum
Preparation of sterically stabilized human serum albumin nanospheres using a novel Dextranox-MPEG crosslinking agent.
Pharmaceutical research 1994;11(11):1588-92.
1994: Lisbeth Illum; N F Farraj; Stanley S Davis
Chitosan as a novel nasal delivery system for peptide drugs.
Pharmaceutical research 1994;11(8):1186-9.
1994: H Critchley; Stanley S Davis; N F Farraj; Lisbeth Illum
Nasal absorption of desmopressin in rats and sheep. Effect of a bioadhesive microsphere delivery system.
The Journal of pharmacy and pharmacology 1994;46(8):651-6.
1994: A G A Coombes; P D Scholes; Martyn C Davies; Lisbeth Illum; Stanley S Davis
Resorbable polymeric microspheres for drug delivery--production and simultaneous surface modification using PEO-PPO surfactants.
Biomaterials 1994;15(9):673-80.
1994: S E Dunn; A Brindley; Stanley S Davis; Martyn C Davies; Lisbeth Illum
Polystyrene-poly (ethylene glycol) (PS-PEG2000) particles as model systems for site specific drug delivery. 2. The effect of PEG surface density on the in vitro cell interaction and in vivo biodistribution.
Pharmaceutical research 1994;11(7):1016-22.
1994: C Q Chen; W Lin; A G A Coombes; Stanley S Davis; Lisbeth Illum
Preparation of human serum albumin microspheres by a novel acetone-heat denaturation method.
Journal of microencapsulation 1994;11(4):395-407.
1994: SM Moghimi; AE Hawley; N M Christy; T Gray; Lisbeth Illum; Stanley S Davis
Surface engineered nanospheres with enhanced drainage into lymphatics and uptake by macrophages of the regional lymph nodes.
FEBS letters 1994;344(1):25-30.
1993: SM Moghimi; H Hedeman; N M Christy; Lisbeth Illum; Stanley S Davis
Enhanced hepatic clearance of intravenously administered sterically stabilized microspheres in zymosan-stimulated rats.
Journal of leukocyte biology 1993;54(6):513-7.
1993: SM Moghimi; I S Muir; Lisbeth Illum; Stanley S Davis; V Kolb-Bachofen
Coating particles with a block co-polymer (poloxamine-908) suppresses opsonization but permits the activity of dysopsonins in the serum.
Biochimica et biophysica acta 1993;1179(2):157-65.
1993: SM Moghimi; H Hedeman; I S Muir; Lisbeth Illum; Stanley S Davis
An investigation of the filtration capacity and the fate of large filtered sterically-stabilized microspheres in rat spleen.
Biochimica et biophysica acta 1993;1157(3):233-40.
1993: M E Norman; Paul Williams; Lisbeth Illum
In vivo evaluation of protein adsorption to sterically stabilised colloidal carriers.
Journal of biomedical materials research 1993;27(7):861-6.
1993: SM Moghimi; H Hedeman; Lisbeth Illum; Stanley S Davis
Effect of splenic congestion associated with haemolytic anaemia on filtration of 'spleen-homing' microspheres.
Clinical science (London, England : 1979) 1993;84(6):605-9.
1993: E S Cahill; D T O'Hagan; Lisbeth Illum; K Redhead
Mice are protected against Bordetella pertussis infection by intra-nasal immunization with filamentous haemagglutinin.
FEMS microbiology letters 1993;107(2-3):211-6.
1993: M E Norman; Paul Williams; Lisbeth Illum
Influence of block copolymers on the adsorption of plasma proteins to microspheres.
Biomaterials 1993;14(3):193-202.
1993: D T O'Hagan; D Rafferty; S Wharton; Lisbeth Illum
Intravaginal immunization in sheep using a bioadhesive microsphere antigen delivery system.
Vaccine 1993;11(6):660-4.
1993: W Lin; A G A Coombes; Martyn C Davies; Stanley S Davis; Lisbeth Illum
Preparation of sub-100 nm human serum albumin nanospheres using a pH-coacervation method.
Journal of drug targeting 1993;1(3):237-43.
1992: D T O'Hagan; D Rafferty; J A McKeating; Lisbeth Illum
Vaginal immunization of rats with a synthetic peptide from human immunodeficiency virus envelope glycoprotein.
The Journal of general virology 1992;73 ( Pt 8)():2141-5.
1992: J L Richardson; Lisbeth Illum; N W Thomas
Vaginal absorption of insulin in the rat: effect of penetration enhancers on insulin uptake and mucosal histology.
Pharmaceutical research 1992;9(7):878-83.
1992: AN Fisher; Lisbeth Illum; Stanley S Davis; E H Schacht
Di-iodo-L-tyrosine-labelled dextrans as molecular size markers of nasal absorption in the rat.
The Journal of pharmacy and pharmacology 1992;44(7):550-4.
1992: C J Porter; SM Moghimi; Lisbeth Illum; Stanley S Davis
The polyoxyethylene/polyoxypropylene block co-polymer poloxamer-407 selectively redirects intravenously injected microspheres to sinusoidal endothelial cells of rabbit bone marrow.
FEBS letters 1992;305(1):62-6.
1992: M E Norman; Paul Williams; Lisbeth Illum
Human serum albumin as a probe for surface conditioning (opsonization) of block copolymer-coated microspheres.
Biomaterials 1992;13(12):841-9.
1991: I S Muir; SM Moghimi; Lisbeth Illum; Stanley S Davis; Martyn C Davies
The effect of block co-polymers on the uptake of model polystyrene microspheres by Kupffer cells--in vitro and in vivo studies.
Biochemical Society transactions 1991;19(3):329S.
1991: SM Moghimi; C J Porter; I S Muir; Lisbeth Illum; Stanley S Davis
Non-phagocytic uptake of intravenously injected microspheres in rat spleen: influence of particle size and hydrophilic coating.
Biochemical and biophysical research communications 1991;177(2):861-6.
1990: D T O'Hagan; H Critchley; N F Farraj; AN Fisher; B R Johansen; Stanley S Davis; Lisbeth Illum
Nasal absorption enhancers for biosynthetic human growth hormone in rats.
Pharmaceutical research 1990;7(7):772-6.
1990: D T O'Hagan; Lisbeth Illum
Absorption of peptides and proteins from the respiratory tract and the potential for development of locally administered vaccine.
Critical reviews in therapeutic drug carrier systems 1990;7(1):35-97.
1990: SM Moghimi; Lisbeth Illum; Stanley S Davis
Physiopathological and physicochemical considerations in targeting of colloids and drug carriers to the bone marrow.
Critical reviews in therapeutic drug carrier systems 1990;7(3):187-209.
1988: Stanley S Davis; Lisbeth Illum
Polymeric microspheres as drug carriers.
Biomaterials 1988;9(1):111-5.
1987: Stanley S Davis; C Washington; P West; Lisbeth Illum; G Liversidge; L Sternson; R Kirsh
Lipid emulsions as drug delivery systems.
Annals of the New York Academy of Sciences 1987;507():75-88.
1986: Lisbeth Illum; N W Thomas; Stanley S Davis
Effect of a selected suppression of the reticuloendothelial system on the distribution of model carrier particles.
Journal of pharmaceutical sciences 1986;75(1):16-22.